Abstract
Murine cytotoxic T (Tc)-cell responses to various antigens are controlled by immune response (Ir) genes mapping in the major histocompatibility complex (H–2). The genes responsible are those encoding the class I and class II H–2 antigens1–4. The H–2 I–Ab mutant mouse strain bm12 differs from its strain of origin, C57BL/6 (H–2b), only in three amino acids in the I–Aβbm12 class II H–2 molecule5–7. As a consequence, female bm12 mice are Tc-cell nonresponders to the male antigen H–Y and do not reject H–Y disparate skin grafts8. We now report that bm12 mice generate strong H–Y-specific Tc cells following priming in vivo and restimulation in vitro with male bm12 dendritic cells (DC). Female bm12 mice primed with male DC also reject male skin grafts. Furthermore, we demonstrate that only responder cell populations containing a mixture of L3T4+ (T-helper (Th) phenotype) and Lyt 2+ (Tc phenotype) T lymphocytes generate H–Y-specific Tc cells. These data imply an essential role for Th cells, activated by DC as antigen-presenting cells (APC), in changing H–Y-nonresponder bml2 mice into H–Y responders. Priming and restimulation with DC allows the triggering of a T-cell repertoire not demonstrable by the usual modes of immunization. This principle might be used to overcome other specific immune response defects.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Melief, C. J. M., Stukart, M. J., de Waal, L. P., Kast, W. M. & Melvold, R. W. Transplantn Proc. 15, 2086–2090 (1983).
Simpson, E. & Gordon, R. D. Immun. Rev. 35, 59–75 (1977).
De Waal, L. P. et al. J. Immun. 130, 665–670 (1983).
von Boehmer, H., Fathman, C. G. & Haas, W. Eur. J. Immun. 7, 443–447 (1977).
McKean, D. J., Melvold, R. W. & David, C. Immunogenetics 14, 41–51 (1981).
Lee, D. R., Hansen, T. H. & Cullen, S. E. J. Immun. 129, 245–251 (1982).
McIntyre, K. R. & Seidman, J. G. Nature 308, 551–553 (1984).
Michaelides, M. et al. J. exp. Med. 153, 464–469 (1981).
Steinman, R. M. & Witmer, M. D. Proc. natn. Acad. Sci. U.S.A. 75, 5132–5136 (1978).
Sunshine, G. H., Katz, D. R. & Feldman, M. J. exp. Med. 152, 1817–1822 (1980).
Nussenzweig, M. C., Steinman, R. M., Gutchinov, B. & Conn, Z. A. J. exp. Med. 152, 1070–1084 (1980).
Röllinghoff, M. K., Pfizenmaier, K. & Wagner, H. Eur. J. Immun. 12, 337–342 (1982).
Sunshine, G. H., Czistrom, A. A. & Katz, D. R. Eur. J. Immun. 12, 9–15 (1982).
Müllbacher, A. & Brenan, M. Nature 258, 34–36 (1980).
McKenzie, I. F. C., Henning, M. M. & Michaelides, M. Immunogenetics 20, 475–480 (1984).
Steinman, R. M., Kaplan, G., Witmer, M. D. & Cohn, Z. J. exp. Med. 149, 1–16 (1979).
Lechler, R. I. & Batchelor, J. R. J. exp. Med. 155, 31–40 (1982).
Faustman, D. L. et al. Proc. natn. Acad. Sci. U.S.A. 81, 3864–3868 (1984).
Matis, L. A. et al. J. exp. Med. 155, 508–523 (1982).
Matis, L. A., Glimcher, L. H., Paul, W. E. & Schwartz, R. H. Proc. natn. Acad. Sci. U.S.A. 80, 6019–6023 (1983).
Bekkhoucha, F., Naquet, P., Pierres, A., Marchetto, S. & Pierres, M. Eur. J. Immun. 14, 807–814 (1984).
McNicolas, J. M. et al. J. exp. Med. 155, 489–507 (1982).
McKenzie, I. F. C., Sandrin, M. S., Morgan, G. M., Henning, M. M. & Melvold, R. W. Immunogenetics 11, 103–106 (1980).
Lafuse, W. P., McGormick, J. F., Melvold, R. W. & David, C. S. Transplantation 31, 434–438 (1981).
Steinman, R. M. & Nussenzweig, M. C. Immun. Rev. 53, 127–147 (1980).
Steinman, R. M. et al. J. exp. Med. 157, 613–627 (1983).
Lin, C.-C. S., Rosenthal, A. S., Passmore, H. C. & Hansen, T. H. Proc. natn. Acad. Sci. U.S.A. 78, 6406–6410 (1981).
Shevach, E. M. & Rosenthal, A. S. J. exp. Med. 138, 1213–1216 (1973).
Nagy, Z. A., Baxevanis, C. N., Ishii, N. & Klein, J. Immun. Rev. 60, 59–83 (1981).
Pierres, A. et al. J. Immun. 132, 2775–2782 (1984).
Ledbetter, J. A. & Herzenberg, L. A. Immun. Rev. 47, 63–90 (1979).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Boog, C., Kast, W., Marc Timmers, H. et al. Abolition of specific immune response defect by immunization with dendritic cells. Nature 318, 59–62 (1985). https://doi.org/10.1038/318059a0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/318059a0
This article is cited by
-
An optimised biphasic culture system for the generation of functional dendritic cells from patients with acute lymphoblastic leukaemia at presentation and in clinical remission
Leukemia (2001)
-
A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell
Nature (1998)
-
Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cells
Nature Medicine (1996)
-
A new fixed cryosection technique for the simultaneous immunocytochemical demonstration of T6 and S100 antigens
The Histochemical Journal (1987)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.